CMAJ • June 20, 2006; 174 (13). doi:10.1503/cmaj.051104.
© 2006 CMA Media Inc. or its licensors
All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association.
This Article
Right arrow Abstract
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Online Appendix
Right arrow Online Appendix
Right arrow Submit a response
Right arrow View responses
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Regier, D. A.
Right arrow Articles by Marra, C. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Regier, D. A.
Right arrow Articles by Marra, C. A.
Related Collections
Right arrow Drugs: cardiovascular system

Cost-effectiveness of self-managed versus physician-managed oral anticoagulation therapy

Dean A. Regier, Rubina Sunderji, Larry D. Lynd, Kenneth Gin and Carlo A. Marra

From the Collaboration for Outcomes Research and Evaluation, Centre for Clinical Epidemiology and Evaluation, Vancouver Coastal Health Research Institute (Regier, Lynd, Marra), the Faculty of Pharmaceutical Sciences (Sunderji, Lynd, Marra), and the University of British Columbia Post-graduate Cardiology Training Program and Faculty of Medicine (Gin), University of British Columbia; and CSU Pharmaceutical Sciences (Sunderji) and the Coronary Care Unit and Echocardiography Laboratory (Gin), Vancouver General Hospital, Vancouver, BC


View this table:

[in a new window]
  		Table 1.

 

View this table:

[in a new window]
  		Table 2.

 

Figure 116
View larger version (25K):

[in a new window]
  		Fig. 1: Joint density of the incremental costs and benefits of each of the 20 000 simulated cost-effectiveness ratios.

 

Figure 216
View larger version (17K):

[in a new window]
  		Fig. 2: Cost-effectiveness acceptability curve of maximum willingness to pay for self-managed anticoagulation therapy versus physician-managed anticoagulation therapy.